{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:52:02Z","timestamp":1781747522750,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48319-3","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:33:47Z","timestamp":1777023227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico analysis of PERK interactions with engineered alpha lactalbumin peptides using molecular dynamics simulations"],"prefix":"10.1038","volume":"16","author":[{"given":"Giti","family":"Pishehvarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mohsen","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Bahramian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"48319_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-12-158","volume":"12","author":"Z-W Liu","year":"2013","unstructured":"Liu, Z.-W. et al. Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc. Diabetol. 12, 1\u201316 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"48319_CR2","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.3233\/JPD-212673","volume":"11","author":"V Kovaleva","year":"2021","unstructured":"Kovaleva, V. & Saarma, M. Endoplasmic reticulum stress regulators: New drug targets for Parkinson\u2019s disease. J. Parkinsons Dis. 11, S219\u2013S228 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"48319_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10484-5","volume":"52","author":"M Mohan","year":"2025","unstructured":"Mohan, M., Mannan, A. & Singh, T. G. Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: A review. Mol. Biol. Rep. 52, 377 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"48319_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062108","volume":"21","author":"W Rozp\u0119dek-Kami\u0144ska","year":"2020","unstructured":"Rozp\u0119dek-Kami\u0144ska, W. et al. The PERK-dependent molecular mechanisms as a novel therapeutic target for neurodegenerative diseases. Int. J. Mol. Sci. 21, 2108 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"48319_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.691881","volume":"13","author":"H Ren","year":"2021","unstructured":"Ren, H., Zhai, W., Lu, X. & Wang, G. The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson\u2019s disease. Front. Aging Neurosci. 13, 691881 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"48319_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1515\/revneuro-2017-0071","volume":"29","author":"YM Taalab","year":"2018","unstructured":"Taalab, Y. M. et al. Mechanisms of disordered neurodegenerative function: Concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK). Rev. Neurosci. 29, 387\u2013415 (2018).","journal-title":"Rev. Neurosci."},{"key":"48319_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1107\/S0907444911006445","volume":"67","author":"W Cui","year":"2011","unstructured":"Cui, W., Li, J., Ron, D. & Sha, B. The structure of the PERK kinase domain suggests the mechanism for its activation. Biol. Crystallogr. 67, 423\u2013428 (2011).","journal-title":"Biol. Crystallogr."},{"key":"48319_CR8","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0024-3205(96)00380-3","volume":"59","author":"WA Banks","year":"1996","unstructured":"Banks, W. A. & Kastin, A. J. Passage of peptides across the blood-brain barrier: Pathophysiological perspectives. Life Sci. 59, 1923\u20131943 (1996).","journal-title":"Life Sci."},{"key":"48319_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.peptides.2015.03.010","volume":"72","author":"WA Banks","year":"2015","unstructured":"Banks, W. A. Peptides and the blood\u2013brain barrier. Peptides 72, 16\u201319 (2015).","journal-title":"Peptides"},{"key":"48319_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1021\/acschemneuro.1c00876","volume":"13","author":"S Ubaid","year":"2022","unstructured":"Ubaid, S. et al. SIRT1 mediates neuroprotective and neurorescue effects of camel \u03b1-lactalbumin and oleic acid complex on rotenone-induced Parkinson\u2019s disease. ACS Chem. Neurosci. 13, 1263\u20131272 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"48319_CR11","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1021\/acschemneuro.0c00639","volume":"11","author":"S Ubaid","year":"2020","unstructured":"Ubaid, S. et al. Elucidating the neuroprotective role of formulated camel \u03b1-lactalbumin\u2013oleic acid complex by curating the SIRT1 pathway in Parkinson\u2019s Disease model. ACS Chem. Neurosci. 11, 4416\u20134425 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"48319_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.peptides.2012.11.016","volume":"39","author":"AB Nongonierma","year":"2013","unstructured":"Nongonierma, A. B. & FitzGerald, R. J. Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides 39, 157\u2013163 (2013).","journal-title":"Peptides"},{"key":"48319_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010094","volume":"12","author":"C Angeloni","year":"2022","unstructured":"Angeloni, C. et al. Mechanisms underlying neurodegenerative disorders and potential neuroprotective activity of agrifood by-products. Antioxidants 12, 94 (2022).","journal-title":"Antioxidants"},{"key":"48319_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/antiox13111284","volume":"13","author":"I Capolupo","year":"2024","unstructured":"Capolupo, I. et al. Exploring endocannabinoid system: Unveiling new roles in modulating ER stress. Antioxidants 13, 1284 (2024).","journal-title":"Antioxidants"},{"key":"48319_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2025.106853","volume":"130","author":"S Pourmand","year":"2025","unstructured":"Pourmand, S., Zareei, S., Jozi, M. & Massahi, S. Computational disruption of paired helical filaments (PHFs) assembly using milk lactalbumin-derived peptides against Alzheimer\u2019s disease. J. Funct. Foods. 130, 106853 (2025).","journal-title":"J. Funct. Foods."},{"key":"48319_CR16","doi-asserted-by":"crossref","unstructured":"Zareei, S., Pourmand, S., Rahimi, N. & Massahi, S. Targeting GSK-beta with peptide inhibitors: A rational computational strategy for Alzheimer\u2019s disease intervention. bioRxiv, 2024.2012. 2030.630755 (2024).","DOI":"10.1101\/2024.12.30.630755"},{"key":"48319_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/1087057114525853","volume":"19","author":"D Pytel","year":"2014","unstructured":"Pytel, D. et al. Enzymatic characterization of ER stress-dependent kinase, PERK, and development of a high-throughput assay for identification of PERK inhibitors. J. Biomol. Screen. 19, 1024\u20131034 (2014).","journal-title":"J. Biomol. Screen."},{"key":"48319_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1747-0285.2010.01048.x","volume":"76","author":"H Wang","year":"2010","unstructured":"Wang, H., Blais, J., Ron, D. & Cardozo, T. Structural determinants of PERK inhibitor potency and selectivity. Chem. Biol. Drug Des. 76, 480\u2013495 (2010).","journal-title":"Chem. Biol. Drug Des."},{"key":"48319_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molmed.2018.04.001","volume":"24","author":"SL Moon","year":"2018","unstructured":"Moon, S. L., Sonenberg, N. & Parker, R. Neuronal regulation of eIF2\u03b1 function in health and neurological disorders. Trends Mol. Med. 24, 575\u2013589 (2018).","journal-title":"Trends Mol. Med."},{"key":"48319_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42689-2","volume":"14","author":"ME Sushkin","year":"2023","unstructured":"Sushkin, M. E., Koehler, C. & Lemke, E. A. Remodeling the cellular stress response for enhanced genetic code expansion in mammalian cells. Nat. Commun. 14, 6931 (2023).","journal-title":"Nat. Commun."},{"key":"48319_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20121221","volume":"449","author":"RA Studer","year":"2013","unstructured":"Studer, R. A., Dessailly, B. H. & Orengo, C. A. Residue mutations and their impact on protein structure and function: Detecting beneficial and pathogenic changes. Biochem. J. 449, 581\u2013594 (2013).","journal-title":"Biochem. J."},{"key":"48319_CR22","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4155\/tde.15.51","volume":"6","author":"J Fominaya","year":"2015","unstructured":"Fominaya, J., Bravo, J. & Rebollo, A. Strategies to stabilize cell penetrating peptides for in vivo applications. Ther. Deliv. 6, 1171\u20131194 (2015).","journal-title":"Ther. Deliv."},{"key":"48319_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/jpp\/rgac038","volume":"74","author":"I Sadeghian","year":"2022","unstructured":"Sadeghian, I., Heidari, R., Raee, M. J. & Negahdaripour, M. Cell-penetrating peptide-mediated delivery of therapeutic peptides\/proteins to manage the diseases involving oxidative stress, inflammatory response and apoptosis. J. Pharm. Pharmacol. 74, 1085\u20131116 (2022).","journal-title":"J. Pharm. Pharmacol."},{"key":"48319_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105625","volume":"146","author":"S Pourmand","year":"2022","unstructured":"Pourmand, S., Zareei, S., Shahlaei, M. & Moradi, S. Inhibition of SARS-CoV-2 pathogenesis by potent peptides designed by the mutation of ACE2 binding region. Comput. Biol. Med. 146, 105625 (2022).","journal-title":"Comput. Biol. Med."},{"key":"48319_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.996005","volume":"13","author":"S Zareei","year":"2022","unstructured":"Zareei, S., Pourmand, S. & Amanlou, M. Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches. Front. Pharmacol. 13, 996005 (2022).","journal-title":"Front. Pharmacol."},{"key":"48319_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","volume":"63","author":"Y Maruyama","year":"2023","unstructured":"Maruyama, Y., Igarashi, R., Ushiku, Y. & Mitsutake, A. Analysis of protein folding simulation with moving root mean square deviation. J. Chem. Inf. Model. 63, 1529\u20131541 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"48319_CR27","first-page":"231","volume-title":"Homology Modeling: Methods and protocols","author":"I Kufareva","year":"2012","unstructured":"Kufareva, I. & Abagyan, R. Homology Modeling: Methods and protocols 231\u2013257 (Springer, 2012)."},{"key":"48319_CR28","unstructured":"Srikakulam, S. K. Simulations and data structures to study drug resistance (2024)."},{"key":"48319_CR29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1073\/pnas.1718910115","volume":"115","author":"Y-w Dong","year":"2018","unstructured":"Dong, Y.-w, Liao, M.-l, Meng, X.-l & Somero, G. N. Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs. Proc. Natl. Acad. Sci. U. S. A. 115, 1274\u20131279 (2018).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"48319_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/polym16131864","volume":"16","author":"R Gardu\u00f1o-Ju\u00e1rez","year":"2024","unstructured":"Gardu\u00f1o-Ju\u00e1rez, R. et al. Molecular dynamic simulations for biopolymers with biomedical applications. Polymers 16, 1864 (2024).","journal-title":"Polymers"},{"key":"48319_CR31","unstructured":"Rangubpit, W. Structure and morphology of magnesium channel by coarse-grained monte carlo and molecular dynamics simulations (2020)."},{"key":"48319_CR32","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1021\/acs.jctc.3c01366","volume":"20","author":"X Cao","year":"2024","unstructured":"Cao, X., Hummel, M. H., Wang, Y., Simmerling, C. & Coutsias, E. A. Exact analytical algorithm for the solvent-accessible surface area and derivatives in implicit solvent molecular simulations on GPUs. J. Chem. Theory Comput. 20, 4456\u20134468 (2024).","journal-title":"J. Chem. Theory Comput."},{"key":"48319_CR33","doi-asserted-by":"publisher","first-page":"25031","DOI":"10.1039\/D4RA02576H","volume":"14","author":"S Raghunathan","year":"2024","unstructured":"Raghunathan, S. Solvent accessible surface area-assessed molecular basis of osmolyte-induced protein stability. RSC Adv. 14, 25031\u201325041 (2024).","journal-title":"RSC Adv."},{"key":"48319_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109245","volume":"183","author":"S Moradi","year":"2024","unstructured":"Moradi, S. et al. A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation. Comput. Biol. Med. 183, 109245 (2024).","journal-title":"Comput. Biol. Med."},{"key":"48319_CR35","volume":"7","author":"S Kaptan","year":"2022","unstructured":"Kaptan, S. & Vattulainen, I. Machine learning in the analysis of biomolecular simulations. Adv. Phys. X 7, 2006080 (2022).","journal-title":"Adv. Phys. X"},{"key":"48319_CR36","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1021\/acs.jpcb.4c06614","volume":"128","author":"B Roux","year":"2024","unstructured":"Roux, B. & Chipot, C. Editorial guidelines for computational studies of ligand binding using MM\/PBSA and MM\/GBSA approximations wisely. J. Phys. Chem. B 128, 12027\u201312029 (2024).","journal-title":"J. Phys. Chem. B"},{"key":"48319_CR37","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: Strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"key":"48319_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/9781608058648115010005","volume-title":"Frontiers in Computational Chemistry","author":"I Maffucci","year":"2015","unstructured":"Maffucci, I. & Contini, A. Tuning the solvation term in the MM-PBSA\/GBSA binding affinity predictions. In Frontiers in Computational Chemistry Vol. 1 82\u2013120 (Bentham Science Publishers, 2015)."},{"key":"48319_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/febs.14422","volume":"286","author":"D Hughes","year":"2019","unstructured":"Hughes, D. & Mallucci, G. R. The unfolded protein response in neurodegenerative disorders\u2013Therapeutic modulation of the PERK pathway. FEBS J. 286, 342\u2013355 (2019).","journal-title":"FEBS J."},{"key":"48319_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jff.2015.06.021","volume":"17","author":"AB Nongonierma","year":"2015","unstructured":"Nongonierma, A. B. & FitzGerald, R. J. The scientific evidence for the role of milk protein-derived bioactive peptides in humans: A review. J. Funct. Foods 17, 640\u2013656 (2015).","journal-title":"J. Funct. Foods"},{"key":"48319_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biom15040524","volume":"15","author":"C Agoni","year":"2025","unstructured":"Agoni, C. et al. Molecular modelling in bioactive peptide discovery and characterisation. Biomolecules 15, 524 (2025).","journal-title":"Biomolecules"},{"key":"48319_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ani10010060","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. A novel SNPs in alpha-lactalbumin gene effects on lactation traits in Chinese Holstein dairy cows. Animals 10, 60 (2019).","journal-title":"Animals"},{"key":"48319_CR43","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1021\/jm300713s","volume":"55","author":"JM Axten","year":"2012","unstructured":"Axten, J. M. et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl) phenyl] acetyl}-2, 3-dihydro-1 H-indol-5-yl)-7 H-pyrrolo [2, 3-d] pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193\u20137207 (2012).","journal-title":"J. Med. Chem."},{"key":"48319_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0696","volume":"8","author":"C Olivieri","year":"2022","unstructured":"Olivieri, C. et al. ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy. Sci. Adv. 8, eabo0696 (2022).","journal-title":"Sci. Adv."},{"key":"48319_CR45","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","volume":"70","author":"M Garcia","year":"2006","unstructured":"Garcia, M. et al. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70, 1032\u20131060 (2006).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"48319_CR46","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","volume":"19","author":"RV Honorato","year":"2024","unstructured":"Honorato, R. V. et al. The HADDOCK2. 4 web server for integrative modeling of biomolecular complexes. Nat. Protoc. 19, 3219\u20133241 (2024).","journal-title":"Nat. Protoc."},{"key":"48319_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.pbiomolbio.2014.05.006","volume":"116","author":"S Salentin","year":"2014","unstructured":"Salentin, S., Haupt, V. J., Daminelli, S. & Schroeder, M. Polypharmacology rescored: Protein\u2013ligand interaction profiles for remote binding site similarity assessment. Prog. Biophys. Mol. Biol. 116, 174\u2013186 (2014).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"48319_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"48319_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman, P. A. et al. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889\u2013897 (2000).","journal-title":"Acc. Chem. Res."},{"key":"48319_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nbd.2018.01.004","volume":"112","author":"G Mercado","year":"2018","unstructured":"Mercado, G. et al. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson\u2019s disease. Neurobiol. Dis. 112, 136\u2013148 (2018).","journal-title":"Neurobiol. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48319-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48319-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48319-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:15:38Z","timestamp":1781745338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48319-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48319"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48319-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This molecular dynamics simulation study utilized exclusively publicly available protein structures from the RCSB PDB database (IDs: 1f6r and 3qd2, and 4G31). No human\/animal subjects, biological samples, or laboratory experiments were involved. Therefore, ethical approval was not required under University of Tehran regulations and international standards for computational research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"18945"}}